Plus Therapeutics announces 1-for-25 reverse stock split
Source: SeekingAlpha
2026-03-31 07:53:24 ET
More on Plus Therapeutics
- Plus Therapeutics, Inc. (PSTV) Discusses Business Update, REYOBIQ Clinical Program Progress, and Recent Financial Offering - Slideshow
- Plus Therapeutics, Inc. (PSTV) Discusses Business Update, REYOBIQ Clinical Program Progress, and Recent Financial Offering Transcript
- Plus Therapeutics GAAP EPS of -$0.29 beats by $0.01, revenue of $5.21M beats by $0.14M
- Plus Therapeutics stock plunges after pricing $15M units offering
- Seeking Alpha’s Quant Rating on Plus Therapeutics
Read the full article on Seeking Alpha
For further details see:
Plus Therapeutics announces 1-for-25 reverse stock split
PLUS THERAPEUTICS Inc.
NASDAQ: PSTV
PSTV Trading
2214.38% G/L:
$3.46 Last:
454,421 Volume:
$3.75 Open:
PSTV Latest News
April 02, 2026 07:30:00 am
Plus Therapeutics Secures Highmark Coverage for CNSide® CSF Assay, Expanding Reimbursement to ~75 Million Covered Lives
March 31, 2026 04:30:00 pm
Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
PSTV Stock Data
$37,787,078
135,702,904
0.32%
20
N/A
Biotechnology & Life Sciences
Healthcare
US
Houston
